RecruitingNot ApplicableNCT06396260

Structural and Functional Networks in ALS: An Insight Into Pseudobulbar Affect


Sponsor

Aalborg University Hospital

Enrollment

50 participants

Start Date

May 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators aim to elucidate characteristics of structural and functional brain connectivity in patients with amyotrophic lateral sclerosis (ALS) and pseudobulbar affect (PBA) using diffusion kurtosis imaging (DKI) and magnetoencephalography (MEG).


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria1

  • Diagnosed with ALS in the last 6 months according to Gold Coast Criteria

Exclusion Criteria14

  • \- Lack of ability to answer survey through own ability or through a surrogate, for example by hand controlled, eye-controlled computer and/or tablet, or through telephone interview.
  • Lack of ability to cooperate.
  • Pregnancy
  • Drug addiction defined as the non-prescribed use of cannabis, opioids, or other narcotics.
  • Alcohol addiction defined as over 21 units weekly.
  • Lesional neurological diseases, such as stroke, tumor or multiple sclerosis
  • Epilepsy
  • Neurodegenerative diseases other than ALS
  • Severe psychiatric disease such as major depression disorder, bipolar disease or schizophrenia
  • Contraindication for MRI and MEG scan according to hospital guidelines
  • Severe liver or kidney disease
  • Dysregulated heart disease
  • Ongoing treatment with any antidepressants or any antipsychotics at recruitment.
  • Diagnosed with frontotemporal dementia.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDiffusion Kurtosis Imaging (DKI)

Non-invasive MRI sequence which extracts information of diffusion signals from complex brain tissue

OTHERResting State Magnetoencephalography

Non-invasive method of measuring resting state brain activity through magnetoencephalography (MEG)


Locations(1)

Aalborg University hospital

Aalborg, Northern Jutland, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06396260


Related Trials